Go to main content

Table on assessment times for Concerned Member State cases

Table 1. Concerned member state cases

	Average assessment time	Target days	Difference between assessment time and target days	No. of cases measured No. of Drug IDs	No. of cases within 30 days	Share of cases within 30 days in per cent
Concerned Member State cases	Average assessment time	Target days	Difference between assessment time and target days	No. of cases measured No. of Drug IDs	No. of cases within 30 days	Share of cases within 30 days in per cent
4th quarter 2022	67	30	37	77	40	52
1st quarter 2023	112	30	82	75	31	41
2nd quarter 2023	89	30	59	80	23	29
3rd quarter 2023	57	30	27	116	55	47
4th quarter 2023	123	30	93	66	23	35
1st quarter 2024	66	30	36	83	36	43
2nd quarter 2024	85	30	55	110	55	50
3rd quarter 2024	108	30	78	130	57	44

Table 2. Concerned member state cases – Human medicines

	Average assessment time	Target days	Difference between assessment time and target days	No. of cases measured No. of Drug IDs	No. of cases within 30 days	Share of cases within 30 days in per cent
Concerned Member State cases - HUM	Average assessment time	Target days	Difference between assessment time and target days	No. of cases measured No. of Drug IDs	No. of cases within 30 days	Share of cases within 30 days in per cent
4th quarter 2022	78	30	48	62	28	45
1st quarter 2023	117	30	87	70	28	40
2nd quarter 2023	90	30	60	70	21	30
3rd quarter 2023	61	30	31	91	42	46
4th quarter 2023	135	30	105	59	18	31
1st quarter 2024	72	30	42	75	28	37
2nd quarter 2024	92	30	62	93	44	47
3rd quarter 2024	119	30	89	106	37	35

Table 3. Concerned member state cases – Veterinary medicines

	Average assessment time	Target days	Difference between assessment time and target days	No. of cases measured No. of Drug IDs	No. of cases within 30 days	Share of cases within 30 days in per cent
Concerned Member State cases - VET	Average assessment time	Target days	Difference between assessment time and target days	No. of cases measured No. of Drug IDs	No. of cases within 30 days	Share of cases within 30 days in per cent
4th quarter 2022	19	30	-11	15	12	80
1st quarter 2023	35	30	5	5	3	60
2nd quarter 2023	80	30	50	10	2	20
3rd quarter 2023	42	30	12	25	13	52
4th quarter 2023	16	30	-14	7	5	71
1st quarter 2024	7	30	-23	8	8	100
2nd quarter 2024	44	30	14	17	11	65
3rd quarter 2024	57	30	27	24	20	83